Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Moodys
Merck
Queensland Health
Harvard Business School
McKinsey
UBS
Covington
Citi
Baxter

Generated: August 18, 2017

DrugPatentWatch Database Preview

METHOCARBAMOL AND ASPIRIN Drug Profile

« Back to Dashboard

Which patents cover Methocarbamol And Aspirin, and when can generic versions of Methocarbamol And Aspirin launch?

Methocarbamol And Aspirin is a drug marketed by Ivax Sub Teva Pharms, Stevens J, Par Pharm, and Mcneil. and is included in four NDAs.

The generic ingredient in METHOCARBAMOL AND ASPIRIN is aspirin; methocarbamol. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.

Summary for Tradename: METHOCARBAMOL AND ASPIRIN

Patents:0
Applicants:4
NDAs:4
Clinical Trials: see list105,552
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METHOCARBAMOL AND ASPIRIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
METHOCARBAMOL AND ASPIRIN
aspirin; methocarbamol
TABLET;ORAL087211-001Dec 22, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mcneil
METHOCARBAMOL AND ASPIRIN
aspirin; methocarbamol
TABLET;ORAL089193-001Feb 12, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Stevens J
METHOCARBAMOL AND ASPIRIN
aspirin; methocarbamol
TABLET;ORAL081145-001Jan 31, 1995RXNoYes► Subscribe► Subscribe► Subscribe
Par Pharm
METHOCARBAMOL AND ASPIRIN
aspirin; methocarbamol
TABLET;ORAL089657-001Nov 4, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Harvard Business School
US Department of Justice
Teva
UBS
Mallinckrodt
Farmers Insurance
Dow
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot